TinaHashiRN said:Steady state is faster than people expect: half-life about five days, so you are at plateau in roughly three to four weeks rather than five.
Before/after bloodwork compilation for the lipid panel — everything in one place for those who want comprehensive data:
| Category | Marker | Before | After 13mo | Change |
|---|---|---|---|---|
| Metabolic | A1C | 7.2% | 5.5% | ⬇️ 1.4% |
| Metabolic | Fasting Glucose | 131 | 90 | ⬇️ 26 |
| Lipids | LDL | 149 | 93 | ⬇️ 41 |
| Lipids | Triglycerides | 221 | 121 | ⬇️ 111 |
| Inflammation | hsCRP | 6.5 | 0.9 | ⬇️ 5.0 |
Every single metabolic marker improved. This is why I'm a believer in this therapy.
Dr.RaviCardio said:Agreed on the mechanism, with the caveat that the head-to-head used semaglutide 1mg, not 2.4mg.
Saving this. It is the first explanation that did not require me to already understand it. Taking it to my next appointment.
TinaHashiRN said:Steady state is faster than people expect: half-life about five days, so you are at plateau in roughly three to four weeks rather than five.
Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. The "tirzepatide is simply better" summary irritates me. It is better on mean weight loss, and the cardiovascular outcome evidence is far thinner than semaglutide's. If the reason for treating is cardiovascular risk rather than weight, the evidence base points the other way.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View Resultspaige_pharma said:Trying to work out whether my panel improved or merely rearranged itself, because two of the numbers went the wrong way.
Advanced lipoprotein testing on the lipid panel — going beyond standard lipid panel:
| Marker | Baseline | Month 8 | Clinical Meaning |
|---|---|---|---|
| LDL-P | 1701 | 1001 | Particle count (more precise than LDL-C) |
| Small dense LDL | 56% | 33% | Atherogenic pattern |
| Remnant cholesterol | 33 | 15 | Triglyceride-rich lipoproteins |
| oxLDL | 66 | 39 | Oxidative stress marker |
The shift from small dense to large buoyant LDL is particularly important — it represents a fundamental change in the atherogenic profile.
Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. No action needed from anybody.